Patent · US Active

Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer

US9051562B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
INRA, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE · FR
Universite Paris SUD (Paris II) · FR

Inventors

David Machover · Villejuif, FR
Pascal Bonnarme · Plaisir, FR

Key dates

Filing date	Jun 15, 2012
Grant date	Jun 9, 2015
Priority date	—
Expiry date	Jun 15, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods and pharmaceutical compositions for treating cancer. More specifically, the invention relates to a polypeptide isolated from Brevibacterium aurantiacum that shows methionine gamma-lyase and homocysteinase activities. The present invention also relates to the use of such a polypeptide for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.